 Pulmonary fibrosis is a prototypic chronic progressive lung disease with high morbidity and mortality worldwide . Novel effective therapeutic agents are urgently needed owing to the limited treatment options in clinic . Herein nagilactone D a natural dinorditerpenoid obtained from

@highlight Nagilactone D suppressed TGF 1 mediated fibrotic process
@highlight Nagilactone D ameliorated bleomycin induced pulmonary fibrosis
@highlight Nagilactone D inhibited TGF Smad signaling pathway.
